annual CFI:
-$143.66M-$131.98M(-1129.79%)Summary
- As of today (June 4, 2025), LGND annual cash flow from investing activities is -$143.66 million, with the most recent change of -$131.98 million (-1129.79%) on December 31, 2024.
- During the last 3 years, LGND annual CFI has fallen by -$174.19 million (-570.67%).
- LGND annual CFI is now -130.77% below its all-time high of $466.92 million, reached on December 31, 2019.
Performance
LGND Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$4.89M+$43.52M(+112.67%)Summary
- As of today (June 4, 2025), LGND quarterly cash flow from investing activities is $4.89 million, with the most recent change of +$43.52 million (+112.67%) on March 31, 2025.
- Over the past year, LGND quarterly CFI has increased by +$8.67 million (+229.64%).
- LGND quarterly CFI is now -98.53% below its all-time high of $332.07 million, reached on September 30, 2020.
Performance
LGND quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$135.00M+$8.67M(+6.03%)Summary
- As of today (June 4, 2025), LGND TTM cash flow from investing activities is -$135.00 million, with the most recent change of +$8.67 million (+6.03%) on March 31, 2025.
- Over the past year, LGND TTM CFI has dropped by -$108.99 million (-419.09%).
- LGND TTM CFI is now -116.76% below its all-time high of $805.40 million, reached on September 30, 2019.
Performance
LGND TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
LGND Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1129.8% | +229.6% | -419.1% |
| 3 y3 years | -570.7% | -95.7% | -270.3% |
| 5 y5 years | -130.8% | -98.4% | -119.8% |
LGND Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -187.8% | at low | -95.7% | +108.9% | -182.5% | +6.0% |
| 5 y | 5-year | -130.8% | at low | -98.5% | +101.3% | -119.8% | +57.3% |
| alltime | all time | -130.8% | +66.1% | -98.5% | +100.8% | -116.8% | +81.6% |
LGND Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $4.89M(-112.7%) | -$135.00M(-6.0%) |
| Dec 2024 | -$143.66M(+1129.8%) | -$38.62M(-17.0%) | -$143.66M(+24.6%) |
| Sep 2024 | - | -$46.51M(-15.1%) | -$115.33M(+30.6%) |
| Jun 2024 | - | -$54.76M(+1350.6%) | -$88.32M(+239.6%) |
| Mar 2024 | - | -$3.77M(-63.3%) | -$26.01M(+122.6%) |
| Dec 2023 | -$11.68M(-107.1%) | -$10.28M(-47.3%) | -$11.68M(+34.6%) |
| Sep 2023 | - | -$19.50M(-358.1%) | -$8.68M(-128.9%) |
| Jun 2023 | - | $7.56M(-28.4%) | $30.00M(-50.2%) |
| Mar 2023 | - | $10.55M(-244.8%) | $60.29M(-63.2%) |
| Dec 2022 | $163.62M(+436.1%) | -$7.28M(-138.0%) | $163.62M(+21.0%) |
| Sep 2022 | - | $19.18M(-49.3%) | $135.19M(+38.2%) |
| Jun 2022 | - | $37.85M(-66.8%) | $97.80M(+23.3%) |
| Mar 2022 | - | $113.88M(-418.9%) | $79.29M(+159.8%) |
| Dec 2021 | $30.52M(-86.8%) | -$35.71M(+96.0%) | $30.52M(-109.7%) |
| Sep 2021 | - | -$18.22M(-194.2%) | -$315.97M(-1020.6%) |
| Jun 2021 | - | $19.34M(-70.3%) | $34.32M(-391.5%) |
| Mar 2021 | - | $65.11M(-117.0%) | -$11.77M(-105.1%) |
| Dec 2020 | $231.65M(-50.4%) | -$382.20M(-215.1%) | $231.65M(-57.9%) |
| Sep 2020 | - | $332.07M(-1341.1%) | $550.67M(+41.9%) |
| Jun 2020 | - | -$26.76M(-108.7%) | $388.12M(-43.0%) |
| Mar 2020 | - | $308.54M(-588.4%) | $680.68M(+45.8%) |
| Dec 2019 | $466.92M(-210.3%) | -$63.18M(-137.3%) | $466.92M(-42.0%) |
| Sep 2019 | - | $169.52M(-36.2%) | $805.40M(+44.4%) |
| Jun 2019 | - | $265.80M(+180.5%) | $557.63M(-289.1%) |
| Mar 2019 | - | $94.78M(-65.6%) | -$294.91M(-30.3%) |
| Dec 2018 | -$423.27M(+434.6%) | $275.30M(-451.8%) | -$423.27M(-42.4%) |
| Sep 2018 | - | -$78.25M(-86.7%) | -$734.75M(+3.0%) |
| Jun 2018 | - | -$586.74M(+1647.2%) | -$713.03M(+718.7%) |
| Mar 2018 | - | -$33.58M(-7.2%) | -$87.09M(+10.0%) |
| Dec 2017 | -$79.18M(-41.1%) | -$36.17M(-36.0%) | -$79.18M(-34.5%) |
| Sep 2017 | - | -$56.54M(-244.2%) | -$120.95M(+103.8%) |
| Jun 2017 | - | $39.20M(-252.7%) | -$59.34M(-26.1%) |
| Mar 2017 | - | -$25.67M(-67.1%) | -$80.32M(-40.2%) |
| Dec 2016 | -$134.41M(+19.1%) | -$77.95M(-1635.1%) | -$134.41M(+97.8%) |
| Sep 2016 | - | $5.08M(-72.1%) | -$67.94M(-31.6%) |
| Jun 2016 | - | $18.22M(-122.8%) | -$99.39M(-47.6%) |
| Mar 2016 | - | -$79.76M(+595.0%) | -$189.82M(+68.2%) |
| Dec 2015 | -$112.86M(+5467.9%) | -$11.48M(-56.5%) | -$112.86M(+9.5%) |
| Sep 2015 | - | -$26.36M(-63.5%) | -$103.10M(+34.5%) |
| Jun 2015 | - | -$72.22M(+2482.2%) | -$76.66M(+1903.6%) |
| Mar 2015 | - | -$2.80M(+63.5%) | -$3.83M(+88.8%) |
| Dec 2014 | -$2.03M(-59.2%) | -$1.71M(-2443.8%) | -$2.03M(+53.7%) |
| Sep 2014 | - | $73.00K(-88.0%) | -$1.32M(-19.4%) |
| Jun 2014 | - | $609.00K(-161.0%) | -$1.64M(-72.4%) |
| Mar 2014 | - | -$998.00K(-0.5%) | -$5.94M(+19.4%) |
| Dec 2013 | -$4.97M(-493.8%) | -$1.00M(+309.4%) | -$4.97M(+23.0%) |
| Sep 2013 | - | -$245.00K(-93.4%) | -$4.04M(-34.4%) |
| Jun 2013 | - | -$3.69M(>+9900.0%) | -$6.17M(+127.0%) |
| Mar 2013 | - | -$34.00K(-52.8%) | -$2.72M(-315.0%) |
| Dec 2012 | $1.26M(-105.0%) | -$72.00K(-97.0%) | $1.26M(-233.8%) |
| Sep 2012 | - | -$2.37M(+878.5%) | -$944.00K(-173.3%) |
| Jun 2012 | - | -$242.00K(-106.1%) | $1.29M(-35.1%) |
| Mar 2012 | - | $3.94M(-273.1%) | $1.98M(-107.9%) |
| Dec 2011 | -$25.13M(-272.8%) | -$2.28M(+1563.5%) | -$25.13M(+15.2%) |
| Sep 2011 | - | -$137.00K(-130.2%) | -$21.82M(+62.7%) |
| Jun 2011 | - | $453.00K(-102.0%) | -$13.41M(+7.2%) |
| Mar 2011 | - | -$23.17M(-2353.8%) | -$12.51M(-186.0%) |
| Dec 2010 | $14.54M(-41.3%) | $1.03M(-87.6%) | $14.54M(-43.2%) |
| Sep 2010 | - | $8.28M(+510.3%) | $25.59M(-15.7%) |
| Jun 2010 | - | $1.36M(-65.1%) | $30.36M(+22.6%) |
| Mar 2010 | - | $3.88M(-67.9%) | $24.77M(+0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $24.77M(-201.4%) | $12.07M(-7.5%) | $24.77M(+4.7%) |
| Sep 2009 | - | $13.05M(-408.5%) | $23.65M(+237.7%) |
| Jun 2009 | - | -$4.23M(-209.2%) | $7.00M(-147.4%) |
| Mar 2009 | - | $3.87M(-64.7%) | -$14.77M(-39.5%) |
| Dec 2008 | -$24.42M(-107.1%) | $10.96M(-404.7%) | -$24.42M(+68.4%) |
| Sep 2008 | - | -$3.60M(-86.2%) | -$14.51M(-29.4%) |
| Jun 2008 | - | -$26.01M(+350.2%) | -$20.56M(-274.6%) |
| Mar 2008 | - | -$5.78M(-127.7%) | $11.78M(-96.6%) |
| Dec 2007 | $343.84M(+74.7%) | $20.88M(-316.4%) | $343.84M(-34.2%) |
| Sep 2007 | - | -$9.65M(-252.6%) | $522.70M(-1.1%) |
| Jun 2007 | - | $6.32M(-98.1%) | $528.61M(+1.6%) |
| Mar 2007 | - | $326.28M(+63.3%) | $520.15M(+164.2%) |
| Dec 2006 | $196.87M(-683.9%) | $199.75M(-5435.1%) | $196.87M(+8692.5%) |
| Sep 2006 | - | -$3.74M(+75.6%) | $2.24M(-86.9%) |
| Jun 2006 | - | -$2.13M(-171.2%) | $17.04M(+92.5%) |
| Mar 2006 | - | $3.00M(-41.5%) | $8.85M(-126.3%) |
| Dec 2005 | -$33.72M(-271.9%) | $5.12M(-53.7%) | -$33.72M(+55.5%) |
| Sep 2005 | - | $11.05M(-207.1%) | -$21.68M(-9.6%) |
| Jun 2005 | - | -$10.32M(-73.9%) | -$23.98M(-12.7%) |
| Mar 2005 | - | -$39.58M(-330.6%) | -$27.47M(-240.1%) |
| Dec 2004 | $19.61M(-237.8%) | $17.16M(+96.0%) | $19.61M(-231.3%) |
| Sep 2004 | - | $8.76M(-163.4%) | -$14.93M(-27.6%) |
| Jun 2004 | - | -$13.82M(-284.0%) | -$20.62M(+518.8%) |
| Mar 2004 | - | $7.51M(-143.2%) | -$3.33M(-76.6%) |
| Dec 2003 | -$14.23M(-88.5%) | -$17.38M(-666.0%) | -$14.23M(-87.9%) |
| Sep 2003 | - | $3.07M(-11.5%) | -$118.00M(-2.8%) |
| Jun 2003 | - | $3.47M(-202.3%) | -$121.42M(-1.8%) |
| Mar 2003 | - | -$3.39M(-97.2%) | -$123.58M(-0.4%) |
| Dec 2002 | -$124.12M(+2875.0%) | -$121.15M(>+9900.0%) | -$124.12M(-9560.3%) |
| Sep 2002 | - | -$342.00K(-126.3%) | $1.31M(-141.8%) |
| Jun 2002 | - | $1.30M(-133.1%) | -$3.14M(+27.0%) |
| Mar 2002 | - | -$3.93M(-191.8%) | -$2.47M(-40.8%) |
| Dec 2001 | -$4.17M(-133.3%) | $4.28M(-189.3%) | -$4.17M(+22.1%) |
| Sep 2001 | - | -$4.79M(-343.4%) | -$3.42M(-181.8%) |
| Jun 2001 | - | $1.97M(-135.0%) | $4.18M(+55.9%) |
| Mar 2001 | - | -$5.63M(-211.8%) | $2.68M(-78.6%) |
| Dec 2000 | $12.51M(-148.5%) | $5.04M(+79.7%) | $12.51M(+120.4%) |
| Sep 2000 | - | $2.80M(+494.9%) | $5.68M(-120.3%) |
| Jun 2000 | - | $471.00K(-88.8%) | -$27.93M(+26.4%) |
| Mar 2000 | - | $4.20M(-333.5%) | -$22.10M(-14.4%) |
| Dec 1999 | -$25.80M(-9.8%) | -$1.80M(-94.2%) | -$25.80M(-44.6%) |
| Sep 1999 | - | -$30.80M(-588.9%) | -$46.60M(+301.7%) |
| Jun 1999 | - | $6.30M(+1160.0%) | -$11.60M(-1.7%) |
| Mar 1999 | - | $500.00K(-102.2%) | -$11.80M(-58.7%) |
| Dec 1998 | -$28.60M(-765.1%) | -$22.60M(-638.1%) | -$28.60M(+853.3%) |
| Sep 1998 | - | $4.20M(-31.1%) | -$3.00M(+50.0%) |
| Jun 1998 | - | $6.10M(-137.4%) | -$2.00M(-60.0%) |
| Mar 1998 | - | -$16.30M(-643.3%) | -$5.00M(-216.3%) |
| Dec 1997 | $4.30M(-42.7%) | $3.00M(-42.3%) | $4.30M(-175.4%) |
| Sep 1997 | - | $5.20M(+67.7%) | -$5.70M(+32.6%) |
| Jun 1997 | - | $3.10M(-144.3%) | -$4.30M(+2.4%) |
| Mar 1997 | - | -$7.00M(0.0%) | -$4.20M(-156.0%) |
| Dec 1996 | $7.50M(-73.8%) | -$7.00M(-206.1%) | $7.50M(-48.3%) |
| Sep 1996 | - | $6.60M(+106.3%) | $14.50M(+83.5%) |
| Jun 1996 | - | $3.20M(-31.9%) | $7.90M(+68.1%) |
| Mar 1996 | - | $4.70M(+20.5%) | $4.70M(+213.3%) |
| Dec 1995 | $28.60M(+2500.0%) | - | - |
| Mar 1995 | - | $3.90M(>+9900.0%) | $1.50M(+36.4%) |
| Dec 1994 | $1.10M | $0.00(-100.0%) | $1.10M(0.0%) |
| Sep 1994 | - | -$5.60M(-275.0%) | $1.10M(-83.6%) |
| Jun 1994 | - | $3.20M(-8.6%) | $6.70M(+91.4%) |
| Mar 1994 | - | $3.50M | $3.50M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual cash flow from investing activities?
- What is the all time high annual CFI for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual CFI year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly CFI year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM cash flow from investing activities?
- What is the all time high TTM CFI for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM CFI year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual cash flow from investing activities?
The current annual CFI of LGND is -$143.66M
What is the all time high annual CFI for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual cash flow from investing activities is $466.92M
What is Ligand Pharmaceuticals Incorporated annual CFI year-on-year change?
Over the past year, LGND annual cash flow from investing activities has changed by -$131.98M (-1129.79%)
What is Ligand Pharmaceuticals Incorporated quarterly cash flow from investing activities?
The current quarterly CFI of LGND is $4.89M
What is the all time high quarterly CFI for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly cash flow from investing activities is $332.07M
What is Ligand Pharmaceuticals Incorporated quarterly CFI year-on-year change?
Over the past year, LGND quarterly cash flow from investing activities has changed by +$8.67M (+229.64%)
What is Ligand Pharmaceuticals Incorporated TTM cash flow from investing activities?
The current TTM CFI of LGND is -$135.00M
What is the all time high TTM CFI for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM cash flow from investing activities is $805.40M
What is Ligand Pharmaceuticals Incorporated TTM CFI year-on-year change?
Over the past year, LGND TTM cash flow from investing activities has changed by -$108.99M (-419.09%)